<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Drug Discovery | Matthew A. Clarke</title>
    <link>https://mclarke1991.github.io/tag/drug-discovery/</link>
      <atom:link href="https://mclarke1991.github.io/tag/drug-discovery/index.xml" rel="self" type="application/rss+xml" />
    <description>Drug Discovery</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 09 Jan 2025 14:22:23 +0000</lastBuildDate>
    <image>
      <url>https://mclarke1991.github.io/media/icon_hu10226378635250344412.png</url>
      <title>Drug Discovery</title>
      <link>https://mclarke1991.github.io/tag/drug-discovery/</link>
    </image>
    
    <item>
      <title>Predicting Personalised Therapeutic Combinations in Non-Small Cell Lung Cancer Using In Silico Modelling</title>
      <link>https://mclarke1991.github.io/publication/nsclc_2025/</link>
      <pubDate>Thu, 09 Jan 2025 14:22:23 +0000</pubDate>
      <guid>https://mclarke1991.github.io/publication/nsclc_2025/</guid>
      <description>&lt;p&gt;Image credit: Adapted from &lt;a href=&#34;https://www.biorxiv.org/content/10.1101/2025.01.07.631497v1&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Clarke, Barker &amp;amp; Nicholls et al., &lt;em&gt;bioRxiv&lt;/em&gt; 2025&lt;/a&gt; (CC-BY 4.0)&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>DNA Damage Repair and Radiotherapy</title>
      <link>https://mclarke1991.github.io/project/radiotherapy/</link>
      <pubDate>Tue, 07 Nov 2023 15:16:27 +0000</pubDate>
      <guid>https://mclarke1991.github.io/project/radiotherapy/</guid>
      <description>&lt;p&gt;Cancers often emerge, in part, due to deficencies in DNA damage repair, making them vulnerable to DNA damaging treatments such as radiotherapy. While radiotherapy efficacy has been increasing, this is mainly due to better targeting of tumour anatomy, but targeted therapy offers the opportunity to radiosensitise tumour cells by targeting vulnerabilities in the tumour biology. We use computational modelling to find such vulnerabilities, and explore potential resistance mechanisms.&lt;/p&gt;
&lt;p&gt;Image credit: Adapted from &lt;a href=&#34;https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.749496/full#h9&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Elbana et al. &lt;em&gt;Front. Oncol&lt;/em&gt; 2021&lt;/a&gt;. &lt;a href=&#34;https://creativecommons.org/licenses/by/4.0/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;CC-BY 4.0&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
